Different Doses of Intraumbilical Oxytocin on the Third Stage of Labor

Berbagai Dosis Oksitosin Intraumbilikal pada Manajemen Aktif Kala III

Abstract

Objective: To compare the dose of oxytocin injected intraumbilicall
towards the duration of the third stage, blood loss volume, hemoglobin
and hematocrit.

Methods: This study is a prospective randomised study with a
control. The control group was given an intramuscular injection of
10 IU oxytocin. The intervention of the three groups intraumbilical
oxytocin treatment dose of 10 IU, 20 IU and 30 IU diluted in 50 ml of
normal saline solution and administered intraumbilically. The
sample selection by purposive sampling and the distribution group
based on systematic random sampling (10 samples each). Data were
taken from the period April 2016-January 2017 with the inclusion
and exclusion criteria. Data were analysed using Chi-square, T-test,
ANOVA and Post hoc tests.

Results: Characteristics study for variables of age, occupation,
parity, education, episiotomy and neonates weight showed homogeneous
characteristics. The mean duration of the third stage for
all groups was between 366.7  159.0 seconds and 440.1  244.99
seconds. While the average number of postpartum haemorrhage for
all group 61.894  226.3ml and 309.5  110.26 ml. There were no
differences in the dose of oxytocin on the duration of the third
stage (p> 0.05) and the amount of bleeding (p> 0.005). There was a
difference of haemoglobin between intervention group of oxytocin
dose of 10 IU and 30 IU intraumbilical (p = 0.031). There was no
difference between the mean hematocrit levels between the groups
(p> 0.005).

Conclusion: There were no differences in the dose of oxytocin
intraumbilical towards the duration of the third stage, the amount
of bleeding and hematocrit levels. The decrease of haemoglobin
greater in 30 IU intraumbilical significantly.

Keywords: duration of the third stage, haemoglobin and hematocrit,
oxytocin intraumbilical, the amount of bleeding